Share Price and Basic Stock Data
Last Updated: December 27, 2025, 9:09 pm
| PEG Ratio | -1.51 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
IVP Ltd, operating within the chemicals sector, reported a price of ₹146 and a market capitalization of ₹151 Cr. The company has shown fluctuating sales, with a peak of ₹661 Cr in FY 2023, followed by a decline to ₹546 Cr in FY 2024, and a marginal drop to ₹539 Cr projected for FY 2025. The quarterly sales figures also reflect this trend, with sales of ₹175.45 Cr in Mar 2023, declining to ₹139.58 Cr by Jun 2023. The gross profit margin, indicated by the operating profit margin (OPM), stood at a modest 3.08%, which is lower than typical sector ranges, suggesting challenges in cost management or pricing power. The company’s sales growth trajectory from ₹557 Cr in FY 2022 to ₹661 Cr in FY 2023 indicates a solid performance in the last fiscal year, but the subsequent declines raise concerns about sustainability. Overall, the revenue fluctuations highlight the need for strategic adjustments to stabilize sales and enhance growth potential.
Profitability and Efficiency Metrics
IVP Ltd’s profitability metrics reveal a mixed performance. The company reported a net profit of ₹28 Cr in FY 2023, which decreased to ₹12 Cr in FY 2024 and is projected to remain at ₹11 Cr in FY 2025. The net profit margin stood at 2.09% in FY 2025, considerably lower than the sector average, indicating potential difficulties in converting sales into profit. The return on equity (ROE) and return on capital employed (ROCE) were recorded at 8.44% and 9.99%, respectively, which are relatively low compared to industry benchmarks, suggesting inefficiencies in generating returns for shareholders. The interest coverage ratio (ICR) of 3.69x indicates that the company can comfortably cover its interest obligations, but the declining operating profit, which fell to ₹25 Cr in FY 2025 from ₹40 Cr in FY 2023, raises concerns about operational efficiency. With an operating profit margin peaking at 8.45% in Mar 2023 and then declining, the company must address its operational challenges to enhance profitability.
Balance Sheet Strength and Financial Ratios
IVP Ltd’s balance sheet reflects a cautious financial position with total borrowings reported at ₹100 Cr and reserves of ₹134 Cr. The debt-to-equity ratio stood at 0.74x, indicating a moderate reliance on debt financing, which is manageable. The current ratio of 1.32x suggests adequate liquidity to meet short-term liabilities, although a quick ratio of 0.91x indicates potential challenges in covering immediate obligations without selling inventory. The company has maintained a consistent book value per share, which grew to ₹134.88 in Mar 2025 from ₹125.48 in Mar 2024. However, the declining trend in total assets, which fell to ₹350 Cr in FY 2025 from ₹385 Cr in FY 2024, raises questions about asset utilization and growth. The operating profit and net profit margins have also decreased, signaling a need for improved operational management. Overall, while the balance sheet shows some strength, the declining trends in profitability and asset management warrant closer scrutiny.
Shareholding Pattern and Investor Confidence
IVP Ltd’s shareholding pattern indicates a strong promoter holding of 71.32%, suggesting significant control by insiders and possibly stability in management decisions. However, the presence of foreign institutional investors (FIIs) remains negligible at 0.00%, which may reflect lower confidence from international investors in the company’s growth prospects. Domestic institutional investors (DIIs) hold a mere 0.02%, further indicating limited institutional interest. The public shareholding stood at 28.67%, which is relatively healthy but could benefit from increased interest to enhance liquidity. The number of shareholders has shown fluctuations, with a peak of 7,095 reported in Sep 2025, indicating some investor engagement. Despite the strong promoter backing, the lack of institutional investment could be a red flag, as it often correlates with lower market confidence. The overall shareholding structure presents a mixed picture, suggesting the need for improved communication and transparency to attract broader investor interest.
Outlook, Risks, and Final Insight
Looking ahead, IVP Ltd faces several strengths and risks that will shape its future. Strengths include strong promoter support, a manageable debt profile, and a history of revenue growth, particularly evident in FY 2023. However, significant risks loom, including declining profitability, low operational efficiency, and a lack of institutional investment that may hinder stock performance. The company must address its cost management and operational inefficiencies to improve profitability margins and attract institutional investors. If IVP Ltd can stabilize its sales and enhance operational efficiencies, it may recover and potentially improve its market valuation. Conversely, continued declines in profitability or failure to adapt to market conditions could pose significant challenges. The company needs to leverage its strengths while addressing its weaknesses to navigate the competitive landscape effectively and enhance shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 102 Cr. | 287 | 456/243 | 238 | 392 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,810 Cr. | 9,851 | 14,250/8,150 | 56.5 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 35.0 Cr. | 117 | 329/109 | 17.3 | 26.9 | 0.86 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 315 Cr. | 394 | 435/163 | 17.5 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,331.00 Cr | 1,554.39 | 65.92 | 334.84 | 0.40% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 162.17 | 167.19 | 156.14 | 175.45 | 139.58 | 141.97 | 122.33 | 142.23 | 138.26 | 122.01 | 129.36 | 149.36 | 138.19 |
| Expenses | 154.01 | 160.17 | 146.50 | 160.62 | 134.69 | 132.95 | 117.24 | 133.40 | 131.44 | 116.48 | 124.28 | 141.59 | 133.94 |
| Operating Profit | 8.16 | 7.02 | 9.64 | 14.83 | 4.89 | 9.02 | 5.09 | 8.83 | 6.82 | 5.53 | 5.08 | 7.77 | 4.25 |
| OPM % | 5.03% | 4.20% | 6.17% | 8.45% | 3.50% | 6.35% | 4.16% | 6.21% | 4.93% | 4.53% | 3.93% | 5.20% | 3.08% |
| Other Income | 0.64 | 5.09 | 9.19 | 0.82 | 0.76 | 0.75 | 0.69 | 0.83 | 0.81 | 0.79 | 1.04 | 0.94 | 1.06 |
| Interest | 2.80 | 3.38 | 3.12 | 2.94 | 2.61 | 2.23 | 2.00 | 1.85 | 1.82 | 1.82 | 2.05 | 2.10 | 2.11 |
| Depreciation | 1.28 | 1.32 | 1.31 | 1.29 | 1.36 | 1.38 | 1.40 | 1.40 | 1.39 | 1.41 | 1.47 | 1.46 | 1.50 |
| Profit before tax | 4.72 | 7.41 | 14.40 | 11.42 | 1.68 | 6.16 | 2.38 | 6.41 | 4.42 | 3.09 | 2.60 | 5.15 | 1.70 |
| Tax % | 25.85% | 22.94% | 28.68% | 25.22% | 29.17% | 24.68% | 28.15% | 26.05% | 22.40% | 30.10% | 27.31% | 25.63% | 30.00% |
| Net Profit | 3.50 | 5.71 | 10.27 | 8.54 | 1.19 | 4.64 | 1.71 | 4.74 | 3.43 | 2.16 | 1.89 | 3.83 | 1.19 |
| EPS in Rs | 3.39 | 5.53 | 9.95 | 8.27 | 1.15 | 4.49 | 1.66 | 4.59 | 3.32 | 2.09 | 1.83 | 3.71 | 1.15 |
Last Updated: August 1, 2025, 7:05 pm
Below is a detailed analysis of the quarterly data for IVP Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 138.19 Cr.. The value appears to be declining and may need further review. It has decreased from 149.36 Cr. (Mar 2025) to 138.19 Cr., marking a decrease of 11.17 Cr..
- For Expenses, as of Jun 2025, the value is 133.94 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 141.59 Cr. (Mar 2025) to 133.94 Cr., marking a decrease of 7.65 Cr..
- For Operating Profit, as of Jun 2025, the value is 4.25 Cr.. The value appears to be declining and may need further review. It has decreased from 7.77 Cr. (Mar 2025) to 4.25 Cr., marking a decrease of 3.52 Cr..
- For OPM %, as of Jun 2025, the value is 3.08%. The value appears to be declining and may need further review. It has decreased from 5.20% (Mar 2025) to 3.08%, marking a decrease of 2.12%.
- For Other Income, as of Jun 2025, the value is 1.06 Cr.. The value appears strong and on an upward trend. It has increased from 0.94 Cr. (Mar 2025) to 1.06 Cr., marking an increase of 0.12 Cr..
- For Interest, as of Jun 2025, the value is 2.11 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.10 Cr. (Mar 2025) to 2.11 Cr., marking an increase of 0.01 Cr..
- For Depreciation, as of Jun 2025, the value is 1.50 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.46 Cr. (Mar 2025) to 1.50 Cr., marking an increase of 0.04 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.70 Cr.. The value appears to be declining and may need further review. It has decreased from 5.15 Cr. (Mar 2025) to 1.70 Cr., marking a decrease of 3.45 Cr..
- For Tax %, as of Jun 2025, the value is 30.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.63% (Mar 2025) to 30.00%, marking an increase of 4.37%.
- For Net Profit, as of Jun 2025, the value is 1.19 Cr.. The value appears to be declining and may need further review. It has decreased from 3.83 Cr. (Mar 2025) to 1.19 Cr., marking a decrease of 2.64 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.15. The value appears to be declining and may need further review. It has decreased from 3.71 (Mar 2025) to 1.15, marking a decrease of 2.56.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:10 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 146 | 163 | 155 | 161 | 270 | 320 | 229 | 290 | 557 | 661 | 546 | 539 | 564 |
| Expenses | 142 | 153 | 140 | 144 | 249 | 310 | 229 | 273 | 521 | 621 | 518 | 514 | 539 |
| Operating Profit | 4 | 11 | 15 | 17 | 21 | 9 | -0 | 16 | 35 | 40 | 28 | 25 | 25 |
| OPM % | 3% | 7% | 9% | 11% | 8% | 3% | -0% | 6% | 6% | 6% | 5% | 5% | 4% |
| Other Income | 2 | 1 | 5 | 1 | 1 | 2 | 2 | 2 | 3 | 16 | 3 | 4 | 4 |
| Interest | 0 | 1 | 0 | 0 | 3 | 8 | 10 | 7 | 10 | 12 | 9 | 8 | 8 |
| Depreciation | 1 | 1 | 1 | 1 | 3 | 3 | 5 | 5 | 5 | 5 | 6 | 6 | 6 |
| Profit before tax | 4 | 10 | 18 | 17 | 16 | 0 | -13 | 7 | 23 | 38 | 17 | 15 | 15 |
| Tax % | 41% | 34% | 42% | 36% | 37% | -1,107% | -33% | 33% | 24% | 26% | 26% | 26% | |
| Net Profit | 2 | 7 | 10 | 11 | 10 | 3 | -9 | 4 | 18 | 28 | 12 | 11 | 11 |
| EPS in Rs | 2.38 | 6.71 | 10.09 | 10.47 | 10.06 | 3.27 | -8.35 | 4.36 | 17.07 | 27.13 | 11.89 | 10.95 | 10.56 |
| Dividend Payout % | 42% | 30% | 20% | 19% | 20% | 31% | 0% | 23% | 9% | 6% | 8% | 9% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 250.00% | 42.86% | 10.00% | -9.09% | -70.00% | -400.00% | 144.44% | 350.00% | 55.56% | -57.14% | -8.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -207.14% | -32.86% | -19.09% | -60.91% | -330.00% | 544.44% | 205.56% | -294.44% | -112.70% | 48.81% |
IVP Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 19% |
| 3 Years: | -1% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 27% |
| 3 Years: | -14% |
| TTM: | -38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 30% |
| 3 Years: | 2% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | 12% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 7:55 am
Balance Sheet
Last Updated: December 4, 2025, 1:27 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 42 | 45 | 52 | 63 | 71 | 71 | 61 | 65 | 81 | 108 | 119 | 129 | 134 |
| Borrowings | 4 | 4 | 0 | 14 | 78 | 143 | 99 | 122 | 157 | 120 | 89 | 104 | 100 |
| Other Liabilities | 35 | 34 | 42 | 47 | 88 | 50 | 49 | 106 | 122 | 147 | 114 | 106 | 87 |
| Total Liabilities | 91 | 93 | 105 | 134 | 247 | 275 | 220 | 304 | 371 | 385 | 333 | 350 | 331 |
| Fixed Assets | 15 | 15 | 16 | 35 | 41 | 59 | 84 | 79 | 77 | 73 | 71 | 72 | 69 |
| CWIP | 0 | 0 | 1 | 2 | 17 | 26 | 0 | 0 | 0 | 2 | 2 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 75 | 78 | 88 | 96 | 188 | 189 | 136 | 224 | 293 | 310 | 260 | 278 | 261 |
| Total Assets | 91 | 93 | 105 | 134 | 247 | 275 | 220 | 304 | 371 | 385 | 333 | 350 | 331 |
Below is a detailed analysis of the balance sheet data for IVP Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 134.00 Cr.. The value appears strong and on an upward trend. It has increased from 129.00 Cr. (Mar 2025) to 134.00 Cr., marking an increase of 5.00 Cr..
- For Borrowings, as of Sep 2025, the value is 100.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 104.00 Cr. (Mar 2025) to 100.00 Cr., marking a decrease of 4.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 87.00 Cr.. The value appears to be improving (decreasing). It has decreased from 106.00 Cr. (Mar 2025) to 87.00 Cr., marking a decrease of 19.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 331.00 Cr.. The value appears to be improving (decreasing). It has decreased from 350.00 Cr. (Mar 2025) to 331.00 Cr., marking a decrease of 19.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 69.00 Cr.. The value appears to be declining and may need further review. It has decreased from 72.00 Cr. (Mar 2025) to 69.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 261.00 Cr.. The value appears to be declining and may need further review. It has decreased from 278.00 Cr. (Mar 2025) to 261.00 Cr., marking a decrease of 17.00 Cr..
- For Total Assets, as of Sep 2025, the value is 331.00 Cr.. The value appears to be declining and may need further review. It has decreased from 350.00 Cr. (Mar 2025) to 331.00 Cr., marking a decrease of 19.00 Cr..
Notably, the Reserves (134.00 Cr.) exceed the Borrowings (100.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | 7.00 | 15.00 | 3.00 | -57.00 | -134.00 | -99.00 | -106.00 | -122.00 | -80.00 | -61.00 | -79.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 134 | 135 | 131 | 135 | 144 | 140 | 147 | 175 | 137 | 115 | 115 | 123 |
| Inventory Days | 43 | 32 | 63 | 80 | 103 | 68 | 62 | 118 | 63 | 62 | 64 | 72 |
| Days Payable | 53 | 44 | 69 | 78 | 109 | 61 | 91 | 162 | 89 | 89 | 86 | 79 |
| Cash Conversion Cycle | 124 | 123 | 126 | 137 | 138 | 147 | 118 | 131 | 110 | 88 | 92 | 116 |
| Working Capital Days | 88 | 84 | 87 | 72 | 17 | -14 | -34 | -15 | 9 | 26 | 38 | 46 |
| ROCE % | 7% | 19% | 24% | 23% | 16% | 5% | -1% | 7% | 15% | 15% | 11% | 10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 10.96 | 11.89 | 27.13 | 17.07 | 4.35 |
| Diluted EPS (Rs.) | 10.96 | 11.89 | 27.13 | 17.07 | 4.35 |
| Cash EPS (Rs.) | 16.50 | 17.25 | 32.16 | 22.02 | 9.25 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 134.88 | 125.48 | 114.89 | 88.78 | 73.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 134.88 | 125.48 | 114.89 | 88.78 | 73.28 |
| Dividend / Share (Rs.) | 1.00 | 1.00 | 1.50 | 1.50 | 1.00 |
| Revenue From Operations / Share (Rs.) | 521.77 | 528.65 | 639.84 | 538.80 | 280.43 |
| PBDIT / Share (Rs.) | 27.86 | 29.88 | 41.13 | 37.18 | 18.11 |
| PBIT / Share (Rs.) | 22.31 | 24.52 | 36.10 | 32.23 | 13.21 |
| PBT / Share (Rs.) | 14.77 | 16.10 | 36.74 | 22.60 | 6.47 |
| Net Profit / Share (Rs.) | 10.95 | 11.89 | 27.12 | 17.07 | 4.36 |
| PBDIT Margin (%) | 5.33 | 5.65 | 6.42 | 6.90 | 6.45 |
| PBIT Margin (%) | 4.27 | 4.63 | 5.64 | 5.98 | 4.71 |
| PBT Margin (%) | 2.83 | 3.04 | 5.74 | 4.19 | 2.30 |
| Net Profit Margin (%) | 2.09 | 2.24 | 4.23 | 3.16 | 1.55 |
| Return on Networth / Equity (%) | 8.11 | 9.47 | 23.60 | 19.22 | 5.94 |
| Return on Capital Employeed (%) | 16.32 | 19.06 | 30.31 | 35.35 | 17.87 |
| Return On Assets (%) | 3.25 | 3.71 | 7.30 | 4.75 | 1.47 |
| Total Debt / Equity (X) | 0.74 | 0.68 | 1.01 | 1.71 | 1.62 |
| Asset Turnover Ratio (%) | 1.59 | 1.53 | 1.75 | 1.65 | 1.10 |
| Current Ratio (X) | 1.32 | 1.29 | 1.18 | 1.05 | 0.95 |
| Quick Ratio (X) | 0.91 | 0.90 | 0.82 | 0.76 | 0.63 |
| Inventory Turnover Ratio (X) | 6.77 | 5.22 | 6.41 | 6.09 | 4.57 |
| Dividend Payout Ratio (NP) (%) | 9.10 | 12.62 | 5.53 | 5.84 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 6.04 | 8.69 | 4.66 | 4.52 | 0.00 |
| Earning Retention Ratio (%) | 90.90 | 87.38 | 94.47 | 94.16 | 0.00 |
| Cash Earning Retention Ratio (%) | 93.96 | 91.31 | 95.34 | 95.48 | 0.00 |
| Interest Coverage Ratio (X) | 3.69 | 3.55 | 3.47 | 3.86 | 2.68 |
| Interest Coverage Ratio (Post Tax) (X) | 2.45 | 2.41 | 2.24 | 2.77 | 1.65 |
| Enterprise Value (Cr.) | 252.41 | 244.62 | 243.20 | 308.69 | 220.98 |
| EV / Net Operating Revenue (X) | 0.46 | 0.44 | 0.36 | 0.55 | 0.76 |
| EV / EBITDA (X) | 8.77 | 7.92 | 5.72 | 8.04 | 11.81 |
| MarketCap / Net Operating Revenue (X) | 0.27 | 0.28 | 0.18 | 0.27 | 0.34 |
| Retention Ratios (%) | 90.89 | 87.37 | 94.46 | 94.15 | 0.00 |
| Price / BV (X) | 1.07 | 1.21 | 1.05 | 1.67 | 1.33 |
| Price / Net Operating Revenue (X) | 0.27 | 0.28 | 0.18 | 0.27 | 0.34 |
| EarningsYield | 0.07 | 0.07 | 0.22 | 0.11 | 0.04 |
After reviewing the key financial ratios for IVP Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 10.96. This value is within the healthy range. It has decreased from 11.89 (Mar 24) to 10.96, marking a decrease of 0.93.
- For Diluted EPS (Rs.), as of Mar 25, the value is 10.96. This value is within the healthy range. It has decreased from 11.89 (Mar 24) to 10.96, marking a decrease of 0.93.
- For Cash EPS (Rs.), as of Mar 25, the value is 16.50. This value is within the healthy range. It has decreased from 17.25 (Mar 24) to 16.50, marking a decrease of 0.75.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 134.88. It has increased from 125.48 (Mar 24) to 134.88, marking an increase of 9.40.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 134.88. It has increased from 125.48 (Mar 24) to 134.88, marking an increase of 9.40.
- For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 521.77. It has decreased from 528.65 (Mar 24) to 521.77, marking a decrease of 6.88.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 27.86. This value is within the healthy range. It has decreased from 29.88 (Mar 24) to 27.86, marking a decrease of 2.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 22.31. This value is within the healthy range. It has decreased from 24.52 (Mar 24) to 22.31, marking a decrease of 2.21.
- For PBT / Share (Rs.), as of Mar 25, the value is 14.77. This value is within the healthy range. It has decreased from 16.10 (Mar 24) to 14.77, marking a decrease of 1.33.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 10.95. This value is within the healthy range. It has decreased from 11.89 (Mar 24) to 10.95, marking a decrease of 0.94.
- For PBDIT Margin (%), as of Mar 25, the value is 5.33. This value is below the healthy minimum of 10. It has decreased from 5.65 (Mar 24) to 5.33, marking a decrease of 0.32.
- For PBIT Margin (%), as of Mar 25, the value is 4.27. This value is below the healthy minimum of 10. It has decreased from 4.63 (Mar 24) to 4.27, marking a decrease of 0.36.
- For PBT Margin (%), as of Mar 25, the value is 2.83. This value is below the healthy minimum of 10. It has decreased from 3.04 (Mar 24) to 2.83, marking a decrease of 0.21.
- For Net Profit Margin (%), as of Mar 25, the value is 2.09. This value is below the healthy minimum of 5. It has decreased from 2.24 (Mar 24) to 2.09, marking a decrease of 0.15.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.11. This value is below the healthy minimum of 15. It has decreased from 9.47 (Mar 24) to 8.11, marking a decrease of 1.36.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.32. This value is within the healthy range. It has decreased from 19.06 (Mar 24) to 16.32, marking a decrease of 2.74.
- For Return On Assets (%), as of Mar 25, the value is 3.25. This value is below the healthy minimum of 5. It has decreased from 3.71 (Mar 24) to 3.25, marking a decrease of 0.46.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.74. This value is within the healthy range. It has increased from 0.68 (Mar 24) to 0.74, marking an increase of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.59. It has increased from 1.53 (Mar 24) to 1.59, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 1.5. It has increased from 1.29 (Mar 24) to 1.32, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has increased from 0.90 (Mar 24) to 0.91, marking an increase of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.77. This value is within the healthy range. It has increased from 5.22 (Mar 24) to 6.77, marking an increase of 1.55.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 9.10. This value is below the healthy minimum of 20. It has decreased from 12.62 (Mar 24) to 9.10, marking a decrease of 3.52.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.04. This value is below the healthy minimum of 20. It has decreased from 8.69 (Mar 24) to 6.04, marking a decrease of 2.65.
- For Earning Retention Ratio (%), as of Mar 25, the value is 90.90. This value exceeds the healthy maximum of 70. It has increased from 87.38 (Mar 24) to 90.90, marking an increase of 3.52.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.96. This value exceeds the healthy maximum of 70. It has increased from 91.31 (Mar 24) to 93.96, marking an increase of 2.65.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.69. This value is within the healthy range. It has increased from 3.55 (Mar 24) to 3.69, marking an increase of 0.14.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.45. This value is below the healthy minimum of 3. It has increased from 2.41 (Mar 24) to 2.45, marking an increase of 0.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 252.41. It has increased from 244.62 (Mar 24) to 252.41, marking an increase of 7.79.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.44 (Mar 24) to 0.46, marking an increase of 0.02.
- For EV / EBITDA (X), as of Mar 25, the value is 8.77. This value is within the healthy range. It has increased from 7.92 (Mar 24) to 8.77, marking an increase of 0.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.28 (Mar 24) to 0.27, marking a decrease of 0.01.
- For Retention Ratios (%), as of Mar 25, the value is 90.89. This value exceeds the healthy maximum of 70. It has increased from 87.37 (Mar 24) to 90.89, marking an increase of 3.52.
- For Price / BV (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.21 (Mar 24) to 1.07, marking a decrease of 0.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has decreased from 0.28 (Mar 24) to 0.27, marking a decrease of 0.01.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in IVP Ltd:
- Net Profit Margin: 2.09%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.32% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.11% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.45
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.91
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.8 (Industry average Stock P/E: 65.92)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.74
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.09%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Shashikant N Redij Marg, Ghorupdeo, Mumbai Maharashtra 400033 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. T K Gowrishankar | Chairman & Non-Exe.Director |
| Mr. Mandar P Joshi | WholeTime Director & CEO |
| Mr. Rajkumar Lekhwani | Non Exe.Non Ind.Director |
| Mr. Anwar Chauhan | Non Exe.Non Ind.Director |
| Mrs. Mala Todarwal | Independent Director |
| Mr. Ranjeev Lodha | Independent Director |
| Mr. Pratik Kadakia | Independent Director |
FAQ
What is the intrinsic value of IVP Ltd?
IVP Ltd's intrinsic value (as of 27 December 2025) is 130.40 which is 10.68% lower the current market price of 146.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 151 Cr. market cap, FY2025-2026 high/low of 224/138, reserves of ₹134 Cr, and liabilities of 331 Cr.
What is the Market Cap of IVP Ltd?
The Market Cap of IVP Ltd is 151 Cr..
What is the current Stock Price of IVP Ltd as on 27 December 2025?
The current stock price of IVP Ltd as on 27 December 2025 is 146.
What is the High / Low of IVP Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of IVP Ltd stocks is 224/138.
What is the Stock P/E of IVP Ltd?
The Stock P/E of IVP Ltd is 13.8.
What is the Book Value of IVP Ltd?
The Book Value of IVP Ltd is 139.
What is the Dividend Yield of IVP Ltd?
The Dividend Yield of IVP Ltd is 0.68 %.
What is the ROCE of IVP Ltd?
The ROCE of IVP Ltd is 9.99 %.
What is the ROE of IVP Ltd?
The ROE of IVP Ltd is 8.44 %.
What is the Face Value of IVP Ltd?
The Face Value of IVP Ltd is 10.0.